<DOC>
	<DOCNO>NCT00264368</DOCNO>
	<brief_summary>In order optimize anti-cytomegalovirus ( CMV ) treatment ganciclovir ( GCV ) , patient multi organ failure treat continuous renal replacement therapy ( RRT ) , information ganciclovir pharmacokinetics set need . The primary objective describe pharmacokinetics ganciclovir critically ill patient acute renal failure treat continuous renal replacement therapy , special emphasis extra-renal clearance distribution volume . Secondary objective investigate co-factors , serum creatinine , weight , general hydration status , rest function native kidney , etc . help describe pharmacokinetics GCV patient continuous RRT well relative influence filtration dialysis GCV elimination different modality treatment .</brief_summary>
	<brief_title>Ganciclovir Pharmacokinetics Patients Undergoing Continuous Renal Replacement Therapy</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<mesh_term>Multiple Organ Failure</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Patients need continuous RRT GCV treatment 18 year age old . Concomitant treatment acyclovir valacyclovir . Patient give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Renal replacement therapy</keyword>
	<keyword>CMV disease</keyword>
</DOC>